|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, July 20, 2017 ) The report "Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020", The global Enteral Feeding Formulas Market is expected to reach USD 5.95 Billion by 2020. This market was valued at USD 4.13 Billion in 2015 and is expected to grow at a CAGR of 7.6% from 2015 to 2020
Browse 187 tables and 72 figures spread through 225 Pages and in-depth TOC on "Enteral Feeding Formulas Market” <||>rnhttp://www.marketsandmarkets.com/Market-Reports/enteral-feeding-formulas-market-74876393.html
Early buyers will receive 10% customization on this reports
The global Enteral Feeding Formulas Market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period. The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare.
The Enteral Feeding Formulas Market is segmented based on product, stage, application, end user, and region. Based on products, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas.
Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care. On the basis of stage, the Enteral Feeding Formulas Market is segmented into adults and pediatrics.
On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. By end user, the Enteral Feeding Formulas Market is segmented into hospitals and long-term care facilities. Long-term care facilities are further segmented into homecare agencies & hospices and nursing homes and assisted living facilities.
The Sample Report For This Report@ <||>rnhttp://www.marketsandmarkets.com/requestsample.asp?id=74876393
The market in North America and Europe is growing at a significant rate owing to the rising geriatric population along with increasing incidences of chronic diseases and disorders, increasing healthcare expenditure, and increasing demand for homecare in these regions. The Asia-Pacific region however is expected to become the growth center for the Enteral Feeding Formulas Market.
The market in Japan, China, and India is likely to witness significant growth during the forecast period, owing to the presence of a large patient pool for chronic diseases and disorders, high incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and growing population in these countries.
Some of the prominent players in the global Enteral Feeding Formulas Market are Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), Fresenius Kabi AG (Germany), Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).
Get The PDF Brochure For This Report@ <||>rnhttp://www.marketsandmarkets.com/pdfdownload.asp?id=74876393
About MarketsandMarkets™:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Rohan
MarketsandMarkets™
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
Tel: 1-888-600-6441
MarketsandMarkets
Mr. Rohan
1-888-600-6441
sales@marketsandmarkets.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
